Health Condition 1: R739- Hyperglycemia, unspecified
Conditions
Interventions
None listed
Sponsors
Dr Arshid Shekh Jabir Shekh
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients having hyperglycemia confirmed by La- boratory Investigation, i.e., OGTT 140 to 199 mg/dl and HbA1c 5.7% to 6.4% 2) Age group between 25 years and 60 years, newly diagnosed with prediabetes within 3 months. 3) Patient willing to sign the consent form for the clinical trial.
Exclusion criteria
Exclusion criteria: 1) Those reporting prior use of medication to treat diabetes mellitus. 2) Alcoholic liver disease, cirrhosis, liver cancer, autoimmune disease; had symptoms of kidney failure or on renal dialysis, 3) Taking steroids for any illness. 4) Gestational diabetes 5) Pregnancy or breastfeeding 6) Previously participate in any study of investigational drugs within 1 month before this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study may provide the better drug of choice for reducing the signs and symptoms of prediabetes that will be assessed after treatment with Pramehari churna and Polyherbal combination.Timepoint: At the end of 30 days (1, 15, 30 days) | — |
Secondary
| Measure | Time frame |
|---|---|
| It may have decreased the severity of observed signs and symptoms.Timepoint: At the end of 30 days (1, 15, 30 days interval) | — |
Countries
India
Contacts
Public ContactDr Arshid Shekh Jabir Shekh
Shri Ayurved Mahavidyalaya, Nagpur
Outcome results
None listed